Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Gross Profit (2021 - 2025)

PAVmed (PAVM) has 5 years of Gross Profit data on record, last reported at -$50000.0 in Q3 2025.

  • For Q3 2025, Gross Profit changed N/A year-over-year to -$50000.0; the TTM value through Sep 2025 reached $6.5 million, changed N/A, while the annual FY2024 figure was -$1.8 million, 87.81% up from the prior year.
  • Gross Profit reached -$50000.0 in Q3 2025 per PAVM's latest filing, down from $175000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $10.1 million in Q4 2022 and bottomed at -$8.5 million in Q4 2021.
  • Average Gross Profit over 5 years is -$1.0 million, with a median of -$1.5 million recorded in 2022.
  • Peak YoY movement for Gross Profit: plummeted 2867.86% in 2022, then soared 282.42% in 2024.
  • A 5-year view of Gross Profit shows it stood at -$8.5 million in 2021, then soared by 219.0% to $10.1 million in 2022, then plummeted by 136.2% to -$3.6 million in 2023, then skyrocketed by 282.42% to $6.6 million in 2024, then plummeted by 100.75% to -$50000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were -$50000.0 in Q3 2025, $175000.0 in Q2 2025, and -$239000.0 in Q1 2025.